We are live on ! Find out more
APLT

Applied Therapeutics

Delisted

APLT was delisted on the 2nd of February, 2026.

73 hedge funds and large institutions have $422M invested in Applied Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 6 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 6

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

34% more capital invested

Capital invested by funds: $315M → $422M (+$107M)

14% more funds holding

Funds holding: 6473 (+9)

9.37% more ownership

Funds ownership: 43.92%53.29% (+9.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
73
Holders Change
+9
Holders Change %
+14.06%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
44
Reduced
6
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SFM
76
Sphera Funds Management
Israel
-$2.22M -67,967 Closed
GPCM
77
Granite Point Capital Management
Massachusetts
-$1.25M -38,240 Closed
D.E. Shaw & Co
78
D.E. Shaw & Co
New York
-$1.19M -36,338 Closed
T. Rowe Price Associates
79
T. Rowe Price Associates
Maryland
-$1.09M -33,385 Closed
Renaissance Technologies
80
Renaissance Technologies
New York
-$637K -19,486 Closed
LCM
81
Laurion Capital Management
New York
-$327K -10,000 Closed
WS
82
Wedbush Securities
California
-$327K -10,000 Closed
Two Sigma Investments
83
Two Sigma Investments
New York
-$256K -7,834 Closed
FC
84
FORA Capital
Florida
-$22K -672 Closed

APLT Hedge Fund Activity: Q2 2020 in Review

73 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2020, worth a combined $422M — up 34% from $315M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new APLT positions and 11 closed out — a net gain of 9 holders — while 44 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $32.2M. The largest seller was Point72 Asset Management, cutting an estimated $12.6M.

  • 73 institutional investors held Applied Therapeutics (APLT) as of Q2 2020, up from 64 in Q1 2020.
  • Funds reported $422M of Applied Therapeutics stock for Q2 2020, up 34% quarter-over-quarter.
  • 20 funds opened new Applied Therapeutics positions in Q2 2020 and 11 closed out, a net change of +9 holders.
  • The largest Applied Therapeutics buyer in Q2 2020 was Fidelity Investments, an estimated $32.2M added.
  • The largest Applied Therapeutics seller in Q2 2020 was Point72 Asset Management, an estimated $12.6M sold.

Based on aggregated 13F filings for Q2 2020.